Smooth Muscle Physiology - ACEM Primary Study Notes

Overview and ED Relevance of Smooth Muscle

Smooth muscle is the effector tissue of the autonomic nervous system and governs the function of blood vessels, airways, the GI tract, the urinary bladder, and the uterus. For the emergency physician, smooth muscle physiology underpins the pathophysiology of anaphylaxis (bronchospasm + vasodilation), hypertensive emergencies, asthma, ureteric colic, and obstetric emergencies, as well as the mechanism of action of key resuscitation drugs including adrenaline, salbutamol, glyceryl trinitrate, and magnesium.

Structural and Functional Comparison with Skeletal Muscle

Despite containing far less myosin than skeletal muscle, smooth muscle generates greater force per unit cross-sectional area. This apparent paradox is explained by the prolonged attachment time of cross-bridges to actin filaments, the slow cycling rate becomes a mechanical advantage for sustained force generation.

Molecular Mechanism of Contraction

Calcium as the Initiating Signal

The universal trigger for smooth muscle contraction is a rise in intracellular calcium ions ($[\text{Ca}^{2+}]_i$). Unlike skeletal muscle, smooth muscle does not contain troponin. Instead, calcium acts through the calmodulin-myosin light chain kinase pathway.

The Calmodulin-MLCK Cascade

The sequence of activation is:

$$\text{Ca}^{2+} \rightarrow \text{Calmodulin} \rightarrow \text{MLCK activation} \rightarrow \text{Myosin light chain phosphorylation} \rightarrow \text{Cross-bridge cycling} \rightarrow \text{Contraction}$$

1. Ca²⁺ binds calmodulin: calmodulin is a ubiquitous regulatory protein analogous in role (but not structure) to troponin
2. Ca²⁺-calmodulin complex activates myosin light chain kinase (MLCK): a phosphorylating enzyme
3. MLCK phosphorylates the regulatory light chain of the myosin head: this phosphorylation is the essential enabling step; without it, myosin cannot interact with actin
4. Phosphorylated myosin head undergoes repetitive cross-bridge cycling with actin: producing force in the same fundamental manner as skeletal muscle

Relaxation: The Role of Myosin Phosphatase

When $[\text{Ca}^{2+}]_i$ falls, the calmodulin-MLCK complex dissociates and kinase activity ceases. However, the myosin light chain remains phosphorylated until myosin phosphatase (located in the cytosol) cleaves the phosphate group from the regulatory chain. Only then does cross-bridge cycling cease and relaxation occur.

Key point: The rate of relaxation is substantially determined by myosin phosphatase activity, this is a pharmacological target (e.g. agents that increase phosphatase activity promote relaxation).

Sources of Calcium for Contraction

Smooth muscle calcium can be sourced from:

• Extracellular influx: through voltage-gated calcium channels (opened during action potentials/spike potentials) and receptor-operated channels
• Intracellular stores: sarcoplasmic reticulum (less extensive than in skeletal muscle)

In gastrointestinal smooth muscle, slow waves alone (which carry sodium, not calcium) do not cause contraction. Contraction occurs during spike potentials superimposed on slow wave peaks, it is during these spikes that significant calcium influx occurs.

Special Properties of Smooth Muscle

1. The Latch Mechanism

Once smooth muscle achieves full contraction, the excitatory signal can be markedly reduced yet full contractile force is maintained. Furthermore, the energy consumed during this sustained contraction can be as little as 1/300th of the energy required for comparable sustained skeletal muscle contraction.

This "latch" state is thought to involve dephosphorylated myosin cross-bridges that remain attached to actin in a non-cycling, force-maintaining state. The latch mechanism:

• Enables tonic contraction of vascular smooth muscle, sphincters, and airways for prolonged periods
• Requires minimal ongoing neuronal or hormonal input
• Is highly energy-efficient, critical for continuous functions like vascular tone regulation

2. Stress-Relaxation and Plasticity

Stress-relaxation describes the ability of smooth muscle in hollow organs to return to near its original tension after being acutely stretched or compressed, over a timeframe of 15 seconds to a few minutes.

Plasticity is the broader property: unlike skeletal muscle, it is impossible to assign a defined resting length to smooth muscle. When stretched and held at a new length, tension first rises then falls, sometimes below pre-stretch levels. Smooth muscle behaves more like a viscous mass than a rigidly structured tissue.

Clinical example: As the urinary bladder fills, intravesical pressure initially rises little despite increasing volume, because of plasticity of the bladder wall. A critical point is eventually reached where the bladder contracts forcefully (the micturition reflex). This same principle explains why a chronically distended viscus (e.g. bladder in retention, gravid uterus) tolerates large volume changes without proportional pressure rise.

3. Force Generation Economy

The trade-off for this economy is the markedly slower contraction velocity, explained by unique smooth muscle myosin isoforms, distinct regulatory protein expression, and the slower calmodulin-dependent activation compared to troponin-mediated activation in skeletal muscle.

Neural and Humoral Control

Autonomic Nervous System Modulation

Smooth muscle (particularly unitary/visceral smooth muscle) demonstrates spontaneous activity in the absence of nervous input. The function of the autonomic nervous system is to modulate activity rather than initiate it.

The relationship is organ-specific and receptor-specific:

Membrane Potential and Excitability

Resting membrane potential of GI smooth muscle averages approximately −56 mV. Changes in this baseline modulate excitability:

Depolarising stimuli (increase excitability):

• Mechanical stretch of the muscle
• Acetylcholine (parasympathetic)
• Various GI hormones

Hyperpolarising stimuli (decrease excitability):

• Noradrenaline / adrenaline
• Sympathetic nerve stimulation

Pharmacological Pathways Targeting Smooth Muscle Relaxation

β₂-Adrenergic Pathway

Activation of β₂ receptors on smooth muscle increases intracellular cyclic AMP (cAMP), which activates protein kinase A. This promotes smooth muscle relaxation by:

• Phosphorylating and inactivating MLCK (reducing myosin phosphorylation)
• Reducing intracellular calcium

ED drugs exploiting this pathway:

• Salbutamol: inhaled or IV bronchodilator for acute severe asthma
• Adrenaline: β₂-mediated bronchodilation + α₁ vasoconstriction in anaphylaxis

Nitric Oxide / cGMP Pathway

Nitric oxide (NO) is a natural signalling molecule released from endothelium that relaxes smooth muscle by raising intracellular cyclic GMP (cGMP):

$$\text{NO} \rightarrow \text{Guanylyl cyclase} \rightarrow \uparrow\text{cGMP} \rightarrow \text{Smooth muscle relaxation}$$

Phosphodiesterase (PDE) normally degrades cGMP → GMP, terminating the signal.

PDE V inhibitors (sildenafil, tadalafil, vardenafil) block this degradation step, prolonging cGMP activity and smooth muscle relaxation. PDE V is found predominantly in:

• Smooth muscle of the corpus cavernosum
• Pulmonary vasculature

This explains their clinical use in pulmonary arterial hypertension, a relevant ED diagnosis in patients presenting with progressive dyspnoea and right heart failure.

Summary of Key Smooth Muscle Pharmacology

Emergency Medicine Relevance

Anaphylaxis

Anaphylaxis involves massive simultaneous dysregulation of smooth muscle across multiple organ systems: bronchospasm (airway smooth muscle contraction via histamine/leukotrienes acting on M₃-like and other receptors), and profound vasodilatation (vascular smooth muscle relaxation via histamine H₁/H₂ and NO-related pathways). Adrenaline addresses both: α₁-mediated vasoconstriction reverses distributive shock; β₂-mediated bronchodilation relieves airway obstruction.

Acute Severe Asthma

The pathophysiological basis of life-threatening bronchospasm is inappropriate activation of airway smooth muscle contraction (M₃ parasympathetic, inflammatory mediators) with failure of bronchodilatory pathways. Salbutamol drives the β₂ → cAMP → MLCK inhibition → relaxation pathway. Ipratropium blocks M₃ muscarinic receptors directly. Magnesium inhibits calcium entry into smooth muscle cells. The latch mechanism explains why prolonged bronchospasm can be sustained with relatively little ongoing neural input.

Ureteric/Biliary Colic

Spasm of ureteric and biliary smooth muscle generates severe colicky pain. Opioids provide analgesia but may increase sphincter tone. NSAIDs reduce prostaglandin-mediated smooth muscle contraction and promote ureteric relaxation, explaining their efficacy in renal colic. Stress-relaxation physiology explains the cyclical, cramping quality of visceral smooth muscle pain.

Hypertensive Emergency

Dysregulated vascular smooth muscle tone (failure of NO-mediated relaxation, excess α-adrenergic stimulation) underlies hypertensive crises. GTN (NO donor) promotes cGMP-mediated vascular relaxation. Phentolamine (α-blocker) is used in catecholamine excess states (phaeochromocytoma, cocaine toxicity) to reverse pathological α₁-mediated vasoconstriction.

Organophosphate / Cholinergic Toxidrome

Excess acetylcholine at muscarinic receptors drives pathological smooth muscle contraction: bronchospasm (life-threatening), increased GI peristalsis, bladder contraction, and miosis. Atropine competitively antagonises M₃ receptors in airways, the primary endpoint of atropine titration in organophosphate poisoning is drying of bronchial secretions and relief of bronchospasm, not heart rate.

Bladder Physiology and Urinary Retention

The plasticity of bladder smooth muscle explains why bladder volumes can reach 500-1000+ mL before the detrusor contracts forcefully. In acute urinary retention, sympathetic overdrive (α₁ at bladder neck sphincter, β₂ relaxation of detrusor) contributes to failure to void, explaining why α₁-blockers (tamsulosin) facilitate micturition and why stress (pain, post-operative state) worsens retention.

Tocolysis and Obstetric Emergencies

Uterine smooth muscle contraction in preterm labour involves the same Ca²⁺-calmodulin-MLCK pathway. β₂ agonists (salbutamol, ritodrine) can inhibit uterine contractions, relevant when an ED clinician encounters preterm labour. Magnesium sulfate acts as a calcium antagonist at smooth muscle, both as a tocolytic and as a bronchodilator in severe asthma.

Key Numbers to Remember

Sources

• ACEM policy documents
• ANZCOR / ARC Resuscitation Guidelines